Searched for
COVAXIN AND CORBEVAX
Biological E, Bharat Biotech together sitting on stockpile of 250 million COVID vaccine dosesAccording to respective company sources, Biological E is holding 200 million doses of its COVID-19 vaccine Corbevax while Bharat Biotech is...- Vaccinated with Covaxin or Covishield? You may take Corbevax as precaution doseThe government has approved Biological E's Corbevax as a precaution dose for those above 18 years fully vaccinated with either Covishield o...
- Health Ministry likely to approve Corbevax as booster for adults vaccinated with Covishield, Covaxin"Corbevax will be considered as a precaution dose after completion of 6 months or 26 weeks from the date of administration of the second do...
- NTAGI has found Corbevax efficient as a booster, govt may soon recommend it: Drug Controller General of IndiaThe National Technical Advisory Group on Immunisation (NTAGI) which reviewed the data of Corbevax earlier had found significant antibody re...
- Govt panel recommends Corbevax as booster for adults vaccinated with Covishield, CovaxinThe COVID-19 Working Group of the National Technical Advisory Group on Immunisation (NTAGI) made the recommendation in its 48th meeting hel...
- Covid shots for 5-12-year kids not yet included in vaccine driveThe NTAGI has approved both vaccines, but has not recommended the government to put those in the immunisation drive, people in the know tol...
- 'Corbevax under WHO's detailed review for emergency use listing'The WHO website states that the rolling data submission has begun on June 10 and the decision date on EUL is yet to be confirmed. The compa...
- Covid panel to decide today on inclusion of Gennova's mRNA jab in vaccine driveThe experts will review its data for its use as a standalone vaccine and will also weigh its benefits as a booster shot and take a decision...
- NTAGI's STSC recommends use of Covaxin, Corbevax for children aged 5-12The Corbevax vaccine has been recommended for 5-12 years old, meanwhile, Covaxin will be used for children aged 6-12 years.
- NTAGI to decide on including Corbevax as a booster dose in inoculation drive"We will review the data of Corbevax in our next meeting slated to happen this month and evaluate if mix and match of vaccines can be allow...
- NTAGI members agree on reducing Covid booster dose gap to 6 months; discuss monkeypoxThe NTAGI's Standing Technical Sub-Committee (STSC), which met on Thursday, also reviewed the findings of a study by the Christian Medical ...
- Corbevax may soon get nod to be used as fresh boosterIndia's drug regulator on Saturday granted approval to Hyderabad-based Biological E's Covid-19 vaccine Corbevax to be allowed as a booster ...
- Corbevax gets DCGI nod as heterologous Covid booster dose for adultsThe vaccine can be administered after 6 months of administration of primary vaccination (two doses) of Covaxin or Covishield vaccines for r...
- Biological E seeks EUA for Corbevax as booster in adults vaccinated with Covishield, CovaxinThe Drugs Controller General Of India (DCGI) had already approved Corbevax, India's first indigenously developed RBD protein subunit vaccin...
- COVID-19: Government to expedite process of recognition of Biological E Corbevax by other countries"It is necessary to quickly initiate the process of recognition of the Corbevax vaccine and its certificate by other countries while Biolog...
- Corbevax jabs reach states, but a decision on its use not yet taken"The states have started receiving the Corbevax doses, but no decision has yet been taken regarding its use, as of now," people in the gove...
- Biological E. COVID shot gets India emergency approval for 12-18 age groupThe company's shot, called Corbevax, is the third vaccine approved for use in children aged 12 and above in India, joining Zydus Cadila's D...
- The more vaccines, vaccinated the betterThe pandemic is not over. There is a need to ensure universal vaccination at home and abroad. India needs to move quickly on its domestic r...
- Experts panel to review applications of Covovax & Corbevax jabs; Merck's Covid drug todayThe subject experts committee (SEC), a body under India's drug regulator, will meet on Monday to review the applications for granting appro...
- Biological E seeks DCGI's nod for phase-3 trial of Corbevax as booster dose in those vaccinated with Covishield or CovaxinCurrently, phase 2/3 clinical trials of the second indigenously developed Corbevax, an RBD protein sub-unit vaccine to be administered in a...
Load More
